66 related articles for article (PubMed ID: 10592789)
1. Screening of drugs inhibiting Epstein-Barr virus replication.
Liu MY; Yen HK; Chern JW; Tsai CH; Yang CS; Chen JY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 May; 29(2):80-9. PubMed ID: 10592789
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.
Zacny VL; Gershburg E; Davis MG; Biron KK; Pagano JS
J Virol; 1999 Sep; 73(9):7271-7. PubMed ID: 10438815
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus infections: prospects for treatment.
Gershburg E; Pagano JS
J Antimicrob Chemother; 2005 Aug; 56(2):277-81. PubMed ID: 16006448
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility in vitro of Epstein-Barr Virus to myristoylated-peptide.
Ourth DD
Peptides; 2010 Jul; 31(7):1409-11. PubMed ID: 20362634
[TBL] [Abstract][Full Text] [Related]
5. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.
Ballout M; Germi R; Fafi-Kremer S; Guimet J; Barguès G; Seigneurin JM; Morand P
J Virol Methods; 2007 Jul; 143(1):38-44. PubMed ID: 17368820
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication.
Lin JC; Reefschläger J; Herrmann G; Pagano JS
Antiviral Res; 1992 Jan; 17(1):43-52. PubMed ID: 1310582
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus replication in interferon-treated cells.
Sharp NA; Arrand JR; Clemens MJ
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2521-6. PubMed ID: 2550580
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro.
Lin JC
Antiviral Res; 2003 Jun; 59(1):41-7. PubMed ID: 12834859
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication.
Meerbach A; Holý A; Wutzler P; De Clercq E; Neyts J
Antivir Chem Chemother; 1998 May; 9(3):275-82. PubMed ID: 9875407
[TBL] [Abstract][Full Text] [Related]
10. [Effect of isonicotinic acid derivates on reproduction of Epstein-Barr virus].
Zahorodnia SD; Nesterova NV; Danylenko VP; Bukhtiarova TA; Baranova HV; Holovan' AV
Mikrobiol Z; 2011; 73(2):65-72. PubMed ID: 21598662
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets.
De Leo A; Arena G; Lacanna E; Oliviero G; Colavita F; Mattia E
Antiviral Res; 2012 Nov; 96(2):196-202. PubMed ID: 22985630
[TBL] [Abstract][Full Text] [Related]
12. Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication.
Lin JC; DeClercq E; Pagano JS
Antimicrob Agents Chemother; 1987 Sep; 31(9):1431-3. PubMed ID: 2823699
[TBL] [Abstract][Full Text] [Related]
13. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
Daibata M; Sairenji T
Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
[TBL] [Abstract][Full Text] [Related]
15. Some nucleoside analogs with anti-human immunodeficiency virus activity inhibit replication of Epstein-Barr virus.
Mar EC; Chu CK; Lin JC
Antiviral Res; 1995 Sep; 28(1):1-11. PubMed ID: 8585756
[TBL] [Abstract][Full Text] [Related]
16. A reporter system for Epstein-Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate.
Auerochs S; Korn K; Marschall M
J Virol Methods; 2011 May; 173(2):334-9. PubMed ID: 21396962
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.
Lin JC; De Clercq E; Pagano JS
Antimicrob Agents Chemother; 1991 Nov; 35(11):2440-3. PubMed ID: 1666500
[TBL] [Abstract][Full Text] [Related]
18. Activity of penciclovir against Epstein-Barr virus.
Bacon TH; Boyd MR
Antimicrob Agents Chemother; 1995 Jul; 39(7):1599-602. PubMed ID: 7492112
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of Epstein-Barr virus reproduction--ribonucleosides of 3-substituted 1,2,4-triazino[5,6-b] [1,4] benzothiasines.
Golovan AJ; Nesterova NV; Zagorodnya SD; Alexeeva LV; Palchykovska LI; Usenko LS; Baranova GV
Mikrobiol Z; 2010; 72(2):36-42. PubMed ID: 20455440
[TBL] [Abstract][Full Text] [Related]
20. Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication.
Wang FZ; Roy D; Gershburg E; Whitehurst CB; Dittmer DP; Pagano JS
J Virol; 2009 Dec; 83(23):12108-17. PubMed ID: 19759127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
